Kindstar's Healthy Biotech is dedicated to providing biomedical technological services as well as R&D, production, and sales of biomedical research reagents. At present, a series of products have been developed and put into production based on PCR, Q-PCR, Sanger sequencing and NGS platforms. The products include those for genetic testing of transplantation and blood diseases, such as myeloid and lymphoid malignancies, hematological genetic diseases, etc., covering all stages of disease management (differential diagnosis, genotyping, prognosis stratification, targeted therapy, and disease monitoring). Our primary goal is to offer a full range of one-stop reagent R&D services, aiming to assist clinical practice in achieving more accurate diagnosis and treatment of patients with blood diseases.